SERPINC1 and bronchopulmonary dysplasia: There were no statistically significant differences for any of the antiproteases between the two groups; however, protection in the No-BPD group was high regardless of the anti-protease used while for the BPD group, maximum protection was achieved by PMSF (has broader anti-protease effect than AAT or ATIII individually).